Sort
51,593 grants matching “hepatitis”
University of Washington Vaccine and Treatment Evaluation Unit
$9,616,028Anna Wald · University Of Washington · UM1 · FY2020 · AI
Oral small molecule inhibitors of NSP4-mediated membrane-associated RNA replication of SARS-CoV-2 and other RNA viruses
$9,266,568Jeffrey S Glenn · Stanford University · U19 · FY2022 · AI
SDMC - IMPAACT Leadership Group
$9,033,216David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2014 · AI
Cardiovascular Inflammation Reduction Trial (CIRT)
$8,957,197Paul M. Ridker · Brigham And Women'S Hospital · U01 · FY2012 · HL
Programmable antivirals: Targeting viral RNA secondary structures with LNAs and small molecules
$8,915,196Jeffrey S Glenn · Stanford University · U19 · FY2022 · AI
NIDA Clinical Trials Network: Big South/West Node
$8,888,943Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2023 · DA
Molecular Assays for epidemiology studies
$8,846,021Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State
$8,680,000Nabila El-Bassel · Columbia Univ New York Morningside · UM1 · FY2022 · DA
NIAAA Repository/Screening Database Management and Research
$8,672,272Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
AIDS Clinical Trial Group Laboratory Center
$8,402,538Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2024 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$8,376,601Barry Coller · Rockefeller University · UL1 · FY2007 · RR
Transforming Clinical and Translational Research and Education at Rockefeller
$8,291,529Barry Coller · Rockefeller University · UL1 · FY2010 · RR
NIAAA Repository/Screening Database Management and Research
$8,273,144Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
AIDS Clinical Trial Group Laboratory Center
$8,265,554Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2022 · AI
AIDS Clinical Trial Group Laboratory Center
$8,196,518Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2023 · AI
Discovery and Optimization of Inhibitors of SARS-CoV-2 Polymerase and Exonuclease
$8,152,463Jingyue Ju · Hackensack University Medical Center · U19 · FY2022 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$8,129,192Barry Coller · Rockefeller University · UL1 · FY2009 · RR
NIDA Clinical Trials Network: Greater New York Node
$8,118,212John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Core C â Drug Metabolism, Pharmacokinetics and Toxicology (DMPK/Tox)
$8,116,465Alexander Kolykhalov · Emory University · U19 · FY2022 · AI
UZCHS CTU
$8,030,499Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2020 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$7,957,771Barry Coller · Rockefeller University · UL1 · FY2008 · RR
COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
$7,930,473Fred M Gordin · Social And Scientific Systems, Inc. · U01 · FY2006 · AI
AIDS Clinical Trial Group Laboratory Center
$7,765,554Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2021 · AI
Trial to Assess Chelation Therapy (TACT)
$7,659,673Mount Sinai Medical Center (Miami Beach) · U01 · FY2003 · AT
DCTD Human Toxicology and Pharmacology
$7,554,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA